LAWRENCE, Mass., Nov. 4, 2014 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced Nancy Lisak, RN, as the winner of its Nurse Hero Campaign. Lisak received over 4,000 votes from patients, care partners and colleagues to top 41 other Nurse Hero nominees. The campaign is a first-of-its-kind home hemodialysis (HHD) nurse recognition that honors the important role these nurses play in helping patients to receive potentially life-changing dialysis therapy. NxStage and Lisak's employer, Affiliated Dialysis Center (ADC), will recognize Lisak at a special ceremony on November 5, 2014 at ADC's corporate headquarters in Glen Ellyn, Illinois.
Faced with kidney disease herself, Lisak identifies directly with the renal failure community and has always believed this career chose her. Her patients at ADC's Elk Grove Village attribute their success with home hemodialysis therapy to her passion, education and support. Social worker Joyce Crement has worked with Lisak for four years at Elk Grove Village and nominated her for the award because of her immense dedication to patients over the course of their work together.
"I am humbled to receive this recognition from both my patients and the renal care community," said Lisak. "I hope this award inspires other home hemodialysis nurses to always strive to exceed patient expectations, build trust, provide the highest quality of care possible, and help patients live independently."
"Nancy's commitment to her patients is truly contagious," said Crement. "She believes in each patient's independence, and helps them develop the confidence to be successful. The genuine relationships she has cultivated demonstrate her strength as an educator and advocate for the best patient care."
"NxStage congratulates Nancy and all 41 other nominees on this wonderful recognition by their patients and peers, whose 13,000 collective votes testify to each nurse's commitment to providing extraordinary patient care," said NxStage President, Joe Turk. "Home hemodialysis nurses deserve this recognition and more, as they play the critical role in ensuring dialyzors have access to life-changing HHD therapy."
Despite the health benefits that home hemodialysis may provide to those with chronic kidney disease, this form of therapy is not for everyone. The reported benefits of home hemodialysis may not be experienced by all patients. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream and blood loss due to clotting or accidental disconnection of the blood tubing set. Certain risks are unique to the home. Treatments at home are done without the presence of medical personnel and on-site technical support. Patients and their partners must be trained on what to do and how to get medical or technical help if needed.
About NxStage Medical, Inc. NxStage is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.
Forward-Looking Statements This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2014. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.